Skip to main content

Advertisement

SpringerLink
Log in

Very high volume hemofiltration with the Cascade system in septic shock patients

  • Seven-Day Profile Publication
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

Abstract

Purpose

We compared hemodynamic and biological effects of the Cascade system, which uses very high volume hemofiltration (HVHF) (120 mL kg−1 h−1), with those of usual care in patients with septic shock.

Methods

Multicenter, prospective, randomized, open-label trial in three intensive care units (ICU). Adults with septic shock with administration of epinephrine/norepinephrine were eligible. Patients were randomized to usual care plus HVHF (Cascade group), or usual care alone (control group). Primary end point was the number of catecholamine-free days up to 28 days after randomization. Secondary end points were number of days free of mechanical ventilation, renal replacement therapy (RRT) or ICU up to 90 days, and 7-, 28-, and 90-day mortality.

Results

We included 60 patients (29 Cascade, 31 usual care). Baseline characteristics were comparable. Median number of catecholamine-free days was 22 [IQR 11–23] vs 20 [0–25] for Cascade vs control; there was no significant difference even after adjustment. There was no significant difference in number of mechanical ventilation-free days or ICU requirement. Median number of RRT-free days was 85 [46–90] vs 74 [0–90] for Cascade vs control groups, p = 0.42. By multivariate analysis, the number of RRT-free days was significantly higher in the Cascade group (up to 25 days higher after adjustment). There was no difference in mortality at 7, 28, or 90 days.

Conclusion

Very HVHF using the Cascade system can safely be used in patients presenting with septic shock, but it was not associated with a reduction in the need for catecholamines during the first 28 days.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Adrie C, Alberti C, Chaix-Couturier C, Azoulay E, De Lassence A, Cohen Y, Meshaka P, Cheval C, Thuong M, Troche G, Garrouste-Orgeas M, Timsit JF (2005) Epidemiology and economic evaluation of severe sepsis in France: age, severity, infection site, and place of acquisition (community, hospital, or intensive care unit) as determinants of workload and cost. J Crit Care 20:46–58

    Article  PubMed  Google Scholar 

  2. Annane D, Bellissant E, Cavaillon JM (2005) Septic shock. Lancet 365:63–78

    Article  CAS  PubMed  Google Scholar 

  3. Quenot JP, Binquet C, Kara F, Martinet O, Ganster F, Navellou JC, Castelain V, Barraud D, Cousson J, Louis G, Perez P, Kuteifan K, Noirot A, Badie J, Mezher C, Lessire H, Pavon A (2013) The epidemiology of septic shock in French intensive care units: the prospective multicenter cohort EPISS study. Crit Care 17:R65

    Article  PubMed Central  PubMed  Google Scholar 

  4. Russell JA (2006) Management of sepsis. N Engl J Med 355:1699–1713

    Article  CAS  PubMed  Google Scholar 

  5. Tolwani A (2012) Continuous renal-replacement therapy for acute kidney injury. N Engl J Med 367:2505–2514

    Article  CAS  PubMed  Google Scholar 

  6. Payen D, Mateo J, Cavaillon JM, Fraisse F, Floriot C, Vicaut E (2009) Impact of continuous venovenous hemofiltration on organ failure during the early phase of severe sepsis: a randomized controlled trial. Crit Care Med 37:803–810

    Article  PubMed  Google Scholar 

  7. Honore PM, Jacobs R, Boer W, Joannes-Boyau O, De Regt J, De Waele E, Van Gorp V, Collin V, Spapen HD (2012) New insights regarding rationale, therapeutic target and dose of hemofiltration and hybrid therapies in septic acute kidney injury. Blood Purif 33:44–51

    Article  CAS  PubMed  Google Scholar 

  8. Journois D, Israel-Biet D, Pouard P, Rolland B, Silvester W, Vouhe P, Safran D (1996) High-volume, zero-balanced hemofiltration to reduce delayed inflammatory response to cardiopulmonary bypass in children. Anesthesiology 85:965–976

    Article  CAS  PubMed  Google Scholar 

  9. Laurent I, Adrie C, Vinsonneau C, Cariou A, Chiche JD, Ohanessian A, Spaulding C, Carli P, Dhainaut JF, Monchi M (2005) High-volume hemofiltration after out-of-hospital cardiac arrest: a randomized study. J Am Coll Cardiol 46:432–437

    Article  PubMed  Google Scholar 

  10. Grootendorst AF, van Bommel EF, van der Hoven B, van Leengoed LA, van Osta AL (1992) High volume hemofiltration improves right ventricular function in endotoxin-induced shock in the pig. Intensive Care Med 18:235–240

    Article  CAS  PubMed  Google Scholar 

  11. Honore PM, Joannes-Boyau O, Boer W, Collin V (2009) High-volume hemofiltration in sepsis and SIRS: current concepts and future prospects. Blood Purif 28:1–11

    Article  PubMed  Google Scholar 

  12. Rimmele T, Wey PF, Bernard N, Monchi M, Semenzato N, Benatir F, Boselli E, Etienne J, Goudable J, Chassard D, Bricca G, Allaouchiche B (2009) Hemofiltration with the Cascade system in an experimental porcine model of septic shock. Ther Apher Dial 13:63–70

    Article  CAS  PubMed  Google Scholar 

  13. (1992) American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864874

  14. Brochard L, Abroug F, Brenner M, Broccard AF, Danner RL, Ferrer M, Laghi F, Magder S, Papazian L, Pelosi P, Polderman KH (2010) An official ATS/ERS/ESICM/SCCM/SRLF statement: prevention and management of acute renal failure in the ICU patient: an international consensus conference in intensive care medicine. Am J Respir Crit Care Med 181:1128–1155

    Article  PubMed  Google Scholar 

  15. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL (2008) Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 36:296–327

    Article  PubMed  Google Scholar 

  16. Moreno RP, Metnitz PG, Almeida E, Jordan B, Bauer P, Campos RA, Iapichino G, Edbrooke D, Capuzzo M, Le Gall JR (2005) SAPS 3—from evaluation of the patient to evaluation of the intensive care unit. Part 2: development of a prognostic model for hospital mortality at ICU admission. Intensive Care Med 31:1345–1355

    Article  PubMed Central  PubMed  Google Scholar 

  17. Vincent JL, de Mendonca A, Cantraine F, Moreno R, Takala J, Suter PM, Sprung CL, Colardyn F, Blecher S (1998) Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on “sepsis-related problems” of the European Society of Intensive Care Medicine. Crit Care Med 26:1793–1800

    Article  CAS  PubMed  Google Scholar 

  18. Clark E, Molnar AO, Joannes-Boyau O, Honore PM, Sikora L, Bagshaw SM (2014) High-volume hemofiltration for septic acute kidney injury: a systematic review and meta-analysis. Crit Care 18:R7

    Article  PubMed Central  PubMed  Google Scholar 

  19. Zhang P, Yang Y, Lv R, Zhang Y, Xie W, Chen J (2012) Effect of the intensity of continuous renal replacement therapy in patients with sepsis and acute kidney injury: a single-center randomized clinical trial. Nephrol Dial Transplant 27:967–973

    Article  CAS  PubMed  Google Scholar 

  20. Joannes-Boyau O, Honore PM, Perez P, Bagshaw SM, Grand H, Canivet JL, Dewitte A, Flamens C, Pujol W, Grandoulier AS, Fleureau C, Jacobs R, Broux C, Floch H, Branchard O, Franck S, Roze H, Collin V, Boer W, Calderon J, Gauche B, Spapen HD, Janvier G, Ouattara A (2013) High-volume versus standard-volume haemofiltration for septic shock patients with acute kidney injury (IVOIRE study): a multicentre randomized controlled trial. Intensive Care Med 39:1535–1546

    Article  PubMed  Google Scholar 

  21. Boussekey N, Chiche A, Faure K, Devos P, Guery B, d’Escrivan T, Georges H, Leroy O (2008) A pilot randomized study comparing high and low volume hemofiltration on vasopressor use in septic shock. Intensive Care Med 34:1646–1653

    Article  CAS  PubMed  Google Scholar 

  22. Yekebas EF, Eisenberger CF, Ohnesorge H, Saalmuller A, Elsner HA, Engelhardt M, Gillesen A, Meins J, The M, Strate T, Busch C, Knoefel WT, Bloechle C, Izbicki JR (2001) Attenuation of sepsis-related immunoparalysis by continuous veno-venous hemofiltration in experimental porcine pancreatitis. Crit Care Med 29:1423–1430

    Article  CAS  PubMed  Google Scholar 

  23. Bellomo R, Kellum JA, Gandhi CR, Pinsky MR, Ondulik B (2000) The effect of intensive plasma water exchange by hemofiltration on hemodynamics and soluble mediators in canine endotoxemia. Am J Respir Crit Care Med 161:1429–1436

    Article  CAS  PubMed  Google Scholar 

  24. Wang H, Zhang ZH, Yan XW, Li WQ, Ji DX, Quan ZF, Gong DH, Li N, Li JS (2005) Amelioration of hemodynamics and oxygen metabolism by continuous venovenous hemofiltration in experimental porcine pancreatitis. World J Gastroenterol 11:127–131

    Article  PubMed Central  PubMed  Google Scholar 

  25. Rogiers P, Zhang H, Pauwels D, Vincent JL (2003) Comparison of polyacrylonitrile (AN69) and polysulphone membrane during hemofiltration in canine endotoxic shock. Crit Care Med 31:1219–1225

    Article  CAS  PubMed  Google Scholar 

  26. Cole L, Bellomo R, Hart G, Journois D, Davenport P, Tipping P, Ronco C (2002) A phase II randomized, controlled trial of continuous hemofiltration in sepsis. Crit Care Med 30:100–106

    Article  CAS  PubMed  Google Scholar 

  27. Bellomo R, Tipping P, Boyce N (1991) Tumor necrosis factor clearances during veno-venous hemodiafiltration in the critically ill. ASAIO Trans 37:M322–M323

    CAS  PubMed  Google Scholar 

  28. Bellomo R, Tipping P, Boyce N (1993) Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patients. Crit Care Med 21:522–526

    Article  CAS  PubMed  Google Scholar 

  29. Honoré PM, Joannes-Boyau O, Gressens B (2007) Blood and plasma treatments: the rationale of high-volume hemofiltration. Contrib Nephrol 156:387–395

    Article  PubMed  Google Scholar 

  30. Klouche K, Cavadore P, Portales P, Clot J, Canaud B, Beraud JJ (2002) Continuous veno-venous hemofiltration improves hemodynamics in septic shock with acute renal failure without modifying TNFalpha and IL6 plasma concentrations. J Nephrol 15:150–157

    PubMed  Google Scholar 

  31. Ronco C, Tetta C, Mariano F, Wratten ML, Bonello M, Bordoni V, Cardona X, Inguaggiato P, Pilotto L, d’Intini V, Bellomo R (2003) Interpreting the mechanisms of continuous renal replacement therapy in sepsis: the peak concentration hypothesis. Artif Organ 27:792–801

    Article  Google Scholar 

  32. Hotchkiss RS, Karl IE (2003) The pathophysiology and treatment of sepsis. N Engl J Med 348:138–150

    Article  CAS  PubMed  Google Scholar 

  33. Cornejo R, Downey P, Castro R, Romero C, Regueira T, Vega J, Castillo L, Andresen M, Dougnac A, Bugedo G, Hernandez G (2006) High-volume hemofiltration as salvage therapy in severe hyperdynamic septic shock. Intensive Care Med 32:713–722

    Article  CAS  PubMed  Google Scholar 

  34. Honore PM, Jamez J, Wauthier M, Lee PA, Dugernier T, Pirenne B, Hanique G, Matson JR (2000) Prospective evaluation of short-term, high-volume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit Care Med 28:3581–3587

    Article  CAS  PubMed  Google Scholar 

  35. Joannes-Boyau O, Rapaport S, Bazin R, Fleureau C, Janvier G (2004) Impact of high volume hemofiltration on hemodynamic disturbance and outcome during septic shock. ASAIO J 50:102–109

    Article  PubMed  Google Scholar 

  36. Oudemans-van Straaten HM, Bosman RJ, van der Spoel JI, Zandstra DF (1999) Outcome of critically ill patients treated with intermittent high-volume haemofiltration: a prospective cohort analysis. Intensive Care Med 25:814–821

    Article  CAS  PubMed  Google Scholar 

  37. Piccinni P, Dan M, Barbacini S, Carraro R, Lieta E, Marafon S, Zamperetti N, Brendolan A, D’Intini V, Tetta C, Bellomo R, Ronco C (2006) Early isovolaemic haemofiltration in oliguric patients with septic shock. Intensive Care Med 32:80–86

    Article  CAS  PubMed  Google Scholar 

  38. Ratanarat R, Brendolan A, Piccinni P, Dan M, Salvatori G, Ricci Z, Ronco C (2005) Pulse high-volume haemofiltration for treatment of severe sepsis: effects on hemodynamics and survival. Crit Care 9:R294–R302

    Article  PubMed Central  PubMed  Google Scholar 

  39. Palevsky PM, Zhang JH, O’Connor TZ, Chertow GM, Crowley ST, Choudhury D, Finkel K, Kellum JA, Paganini E, Schein RM, Smith MW, Swanson KM, Thompson BT, Vijayan A, Watnick S, Star RA, Peduzzi P (2008) Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 359:7–20

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We thank all the following contributors to the study: Dijon University Hospital (Elisabeth Cornot and Thérèse Devaux as well as the nursing team); Clermont-Ferrand University Hospital (Mireille Adda and the nursing team); Melun Hospital (Cécile Lormail and the nursing team); and the Gambro study team (Nicolas Semenzato, Nathalie Loughraieb and Hiram Rada). The authors also thank Fiona Ecarnot (EA3920, University Hospital Besancon, France) for translation and editorial assistance.

Author information

Authors and Affiliations

  1. Intensive Care Unit, University Hospital of Dijon, Dijon, France

    Jean-Pierre Quenot & Rémi Bruyère

  2. Clinical Epidemiology Unit, INSERM, CIC1432, Dijon, France

    Jean-Pierre Quenot, Christine Binquet & Sandrine Vinault

  3. Lipness Team, INSERM, Research Center UMR866 and LabEx LipSTIC, Université de Bourgogne, Dijon, France

    Jean-Pierre Quenot, Valerie Deckert, Stéphanie Lemaire & Laurent Lagrost

  4. Clinical Epidemiology/Clinical Trials Unit, Clinical Investigation Centre, Dijon University Hospital, Dijon, France

    Christine Binquet & Sandrine Vinault

  5. Intensive Care Unit, Hospital of Melun, Melun, France

    Christophe Vinsonneau & Christophe Adrie

  6. Intensive Care Unit, University of Nimes, Nimes, France

    Saber-David Barbar

  7. Clinical Research Department, University Hospital of Dijon, Dijon, France

    Valerie Deckert, Stéphanie Lemaire & Laurent Lagrost

  8. Intensive Care Unit, University Hospital of Clermont-Ferrand, Clermont-Ferrand, France

    Ali Ait Hassain & Bertrand Souweine

  9. Physiology Department, Cochin Hospital, Paris, France

    Christophe Adrie

Authors
  1. Jean-Pierre Quenot
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christine Binquet
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Christophe Vinsonneau
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Saber-David Barbar
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sandrine Vinault
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Valerie Deckert
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Stéphanie Lemaire
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Ali Ait Hassain
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Rémi Bruyère
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Bertrand Souweine
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Laurent Lagrost
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Christophe Adrie
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jean-Pierre Quenot.

Ethics declarations

Conflicts of interest

The authors of this paper have no conflicts of interest to report.

Funding

This study was sponsored by Gambro Industries, Meyzieu, France.

Additional information

For the Cascade study group.

Take-home message: Very high volume hemofiltration using the Cascade system can safely be used in patients presenting with septic shock, but it is not associated with a reduction in the need for catecholamines during the first 28 days.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOC 687 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Quenot, JP., Binquet, C., Vinsonneau, C. et al. Very high volume hemofiltration with the Cascade system in septic shock patients. Intensive Care Med 41, 2111–2120 (2015). https://doi.org/10.1007/s00134-015-4056-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-015-4056-y

Keywords

Search

Navigation